---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-22-000026"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2022-04-20T23:59:59+00:00"
generated_at: "2026-06-26T06:24:32.601067+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# ICU Medical amends CEO Vivek Jain's contract: base salary $775K, enhanced equity vesting

## Summary
- CEO Jain's base salary to $775,000 under amended employment agreement effective March 1, 2022 through March 2025.
- Upon involuntary termination, equity awards granted Jan 2020-Dec 2021 vest fully (performance at target).
- For termination near a change in control (60 days before to 2 years after), all time-based equity awards vest in full.
- Agreement term until March 1, 2025, with automatic one-year renewals unless 60 days' notice.

## SEC filing metadata
- accession: 0000883984-22-000026
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2022-04-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398422000026/0000883984-22-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398422000026/icui-20220415.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-22-000026
- JSON: https://secwatch.observer/filing/0000883984-22-000026.json
- Plain text: https://secwatch.observer/filing/0000883984-22-000026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.